Henlius (2696 HK): LVC Sits On A Blocking Stake. And Me (Maybe) Eating Humble Pie
I didn't expect LVC to do anything other than take scrip. And they may just do that. It should be this straightforward; but the fact that it is not...
727 Views
Pre-IPO B&K Corporation - Valuation Performance Could Be Disappointing
Pro-101will face fierce competition. Due to uncertain market acceptance, B&K has to invest heavily in market education. Valuation of peers is under...
441 Views
Shanghai Henlius (复宏汉霖) IPO: Thoughts on Price Range, Cornerstone, Valuation Trap
Shanghai Henlius, a biotech subsidiary of Fosun Pharma, launched book building today to raise up to USD 477 million. In our previous insights...
1k Views
No more insights